Noelle Frey, an assistant professor of Medicine and an oncologist at Penn's Abramson's Cancer Center, has recently demonstrated a new T-cell engineering technique on treating patients with acute lymphoblastic leukemia (ALL). This gene transfer technique is able to train patient’s own T cells to target and kill the cancerous B cells to achieve long-lasting remissions.
See original article at: https://www.hngn.com/articles/46123/20141016/new-leukemia-therapy-puts-90-percent-of-those-treated-into-remission.htm
Post a comment